OSX2:F:F-Ossiam Lux - Ossiam US Minimum Variance NR (EUR)

ETF | Others |

Last Closing

USD 279.5

Change

0.00 (0.00)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-25 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

+0.12 (+0.44%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.17 (+0.33%)

USD 115.48B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.21 (+0.38%)

USD 95.20B
SXR8:F iShares Core S&P 500 UCITS ETF..

+0.26 (+0.05%)

USD 88.54B
FRCJ:F UBS MSCI Japan Socially Respon..

+0.16 (+0.74%)

USD 75.49B
EUNL:F iShares Core MSCI World UCITS ..

+0.04 (+0.04%)

USD 72.04B
SXRZ:F iShares VII PLC - iShares Nikk..

+0.25 (+0.11%)

USD 56.16B
XDNY:F Xtrackers MSCI Japan ESG Scree..

+0.05 (+0.35%)

USD 56.02B
VUAA:F Vanguard S&P 500 UCITS Acc

N/A

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

N/A

USD 51.63B

ETFs Containing OSX2:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.32% 77% C+ 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.32% 74% C 64% D
Trailing 12 Months  
Capital Gain 14.15% 61% D- 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.15% 59% D- 58% F
Trailing 5 Years  
Capital Gain 44.03% 65% D 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 44.03% 64% D 53% F
Average Annual (5 Year Horizon)  
Capital Gain 6.37% 65% D 65% D
Dividend Return 6.37% 64% D 59% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 9.88% 64% D 85% B
Risk Adjusted Return 64.46% 84% B 87% B+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike